Martins-Gomes C, Silva A
J Xenobiot. 2023; 13(2):172-192.
PMID: 37092502
PMC: 10123636.
DOI: 10.3390/jox13020014.
Sindhu K, Nehlsen A, Lehrer E, Rowley J, Stock R, Galsky M
Biomedicines. 2022; 10(10).
PMID: 36289743
PMC: 9599608.
DOI: 10.3390/biomedicines10102481.
Ronaldson P, Davis T
Pharmaceutics. 2022; 14(7).
PMID: 35890396
PMC: 9324459.
DOI: 10.3390/pharmaceutics14071501.
Xia D, Zhou F, Esser L
Cancer Drug Resist. 2022; 2(3):471-489.
PMID: 35582581
PMC: 8992534.
DOI: 10.20517/cdr.2019.22.
Callaghan R, Board M
Cancer Drug Resist. 2022; 4(2):503-511.
PMID: 35582026
PMC: 9019269.
DOI: 10.20517/cdr.2020.105.
Research advances in the role and pharmaceuticals of ATP-binding cassette transporters in autoimmune diseases.
Yu J, Chen H, Xu J, Zhou P
Mol Cell Biochem. 2022; 477(4):1075-1091.
PMID: 35034257
DOI: 10.1007/s11010-022-04354-y.
Multidrug Resistance in Mammals and Fungi-From MDR to PDR: A Rocky Road from Atomic Structures to Transport Mechanisms.
Khunweeraphong N, Kuchler K
Int J Mol Sci. 2021; 22(9).
PMID: 33946618
PMC: 8124828.
DOI: 10.3390/ijms22094806.
Disease-Induced Modulation of Drug Transporters at the Blood-Brain Barrier Level.
Al Rihani S, Darakjian L, Deodhar M, Dow P, Turgeon J, Michaud V
Int J Mol Sci. 2021; 22(7).
PMID: 33916769
PMC: 8038419.
DOI: 10.3390/ijms22073742.
Combination of coumarin and doxorubicin induces drug-resistant acute myeloid leukemia cell death.
Al-Abbas N, Shaer N
Heliyon. 2021; 7(3):e06255.
PMID: 33786386
PMC: 7988287.
DOI: 10.1016/j.heliyon.2021.e06255.
Targeting tumor resistance mechanisms.
Gerard L, Duvivier L, Gillet J
Fac Rev. 2021; 10:6.
PMID: 33659924
PMC: 7894262.
DOI: 10.12703/r/10-6.
Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
Teng Y, Wang C, Liao W, Lan Y, Hung C
Molecules. 2020; 25(2).
PMID: 31936160
PMC: 7024235.
DOI: 10.3390/molecules25020247.
LY2228820 induces synergistic anti-cancer effects with anti-microtubule chemotherapeutic agents independent of P-glycoprotein in multidrug resistant cancer cells.
Chen R, Qiao Y, Hu W, Cheng Q, Xie H, Zhou L
Am J Cancer Res. 2019; 9(10):2216-2232.
PMID: 31720084
PMC: 6834474.
P-glycoprotein and chronic rhinosinusitis.
Miyake M, Nocera A, Miyake M
World J Otorhinolaryngol Head Neck Surg. 2018; 4(3):169-174.
PMID: 30506047
PMC: 6251952.
DOI: 10.1016/j.wjorl.2018.07.002.
Cell Migration Related to MDR-Another Impediment to Effective Chemotherapy?.
Kryczka J, Boncela J
Molecules. 2018; 23(2).
PMID: 29401721
PMC: 6017720.
DOI: 10.3390/molecules23020331.
LysoTracker and MitoTracker Red are transport substrates of P-glycoprotein: implications for anticancer drug design evading multidrug resistance.
Zhitomirsky B, Farber H, Assaraf Y
J Cell Mol Med. 2018; 22(4):2131-2141.
PMID: 29377455
PMC: 5867146.
DOI: 10.1111/jcmm.13485.
Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.
Dewanjee S, Dua T, Bhattacharjee N, Das A, Gangopadhyay M, Khanra R
Molecules. 2017; 22(6).
PMID: 28587082
PMC: 6152721.
DOI: 10.3390/molecules22060871.
Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?.
Abdullahi W, Davis T, Ronaldson P
AAPS J. 2017; 19(4):931-939.
PMID: 28447295
PMC: 5505261.
DOI: 10.1208/s12248-017-0081-9.
The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.
El-Awady R, Saleh E, Hashim A, Soliman N, Dallah A, Elrasheed A
Front Pharmacol. 2017; 7:535.
PMID: 28119610
PMC: 5223437.
DOI: 10.3389/fphar.2016.00535.
Natural polyphenols: Influence on membrane transporters.
Hussain S, Sulaiman A, Alhaddad H, Alhadidi Q
J Intercult Ethnopharmacol. 2016; 5(1):97-104.
PMID: 27069731
PMC: 4805155.
DOI: 10.5455/jice.20160118062127.
Blood brain barrier: a challenge for effectual therapy of brain tumors.
Bhowmik A, Khan R, Ghosh M
Biomed Res Int. 2015; 2015:320941.
PMID: 25866775
PMC: 4383356.
DOI: 10.1155/2015/320941.
